Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: Synergistic effects of MBP 68-86 and 87-99

International Immunology

Volumn 10, Issue 8, 1998, Pages 1139-1148

  Liu, Jin Qing ^a   Bai, Xue Feng ^a   Shi, Fu Dong ^a   Xiao, Bao Guo ^a   Li, Hu Lun ^a   Levi, Michael ^b   Mustafa, Maha ^a   Wahren, Britta ^b   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Cytokine; ELISPOT; Experimental autoimmune encephalomyelitis; Mucosal tolerance; Nasal route

Indexed keywords

ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; MYELIN BASIC PROTEIN; SYNTHETIC PEPTIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; GUINEA PIG; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INTRANASAL DRUG ADMINISTRATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; DRUG SYNERGISM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031927667     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.8.1139     Document Type: Article

References (59)

1. Vandenbark, A. A., Offner, H., Reshef, T., Fritz, R., Chou, C. H. and Cohen, I. R. 1985. Specificity of T lymphocyte lines for peptides of myelin basic protein. J. Immunol. 135:229.
2. Hashim, G. A. 1977. Experimental allergic encephalomyelitis in Lewis rats: chemical synthesis of disease-inducing determinant. Science 196:1219.
3. Mannie, M. D., Paterson, P. Y., U'Prichard, D. C. and Flouret, G. 1985. Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes. Proc. Natl Acad. Sci. USA 82:5515.
4. Burns, F. R., Li, X. B., Shen, N., Offner, H., Chou, Y. K., Vandenbark, A. A. and Heber-Katz, E. 1989. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169:27.
5. Chluba, J., Steeg, C., Becker, A., Wekerle, H. and Epplen, J. T. 1989. T cell receptor beta chain usage in myelin basic protein specific rat T lymphocytes. Eur. J. Immunol. 19:279.
6. Offner, H., Hashim, G. A., Celnik, B., Galang, A., Li, X. B., Burns, F. R., Shen, N., Heber-Katz, E. and Vandenbark, A. A. 1989. T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats. J. Exp. Med. 170:355.
7. β8 receptors. Eur. J. Immunol. 22:591.
8. Gould, K. E. and Swanborg, R. H. 1993. T and B cell responses to myelin basic protein and encephalitogenic epitopes. J. Neuroimmunol. 46:193.
9. Gold, D. P., Vainiene, M., Celnik, B., Wiley, S., Gibbs, C., Hashim, G. A., Vandenbark, A. A. and Offner, H. 1992. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rat. II. Biased T cell receptor V beta expression predominates in spinal cord-infiltrating T cells. J Immunol 148:1712.
10. Sakai, K., Sinka, H., Mitchell, D. J., Zamvil, S. S., Rothbard, J. B. and Steinman, L. 1988. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc. Natl Acad. Sci. USA 85:8608.
11. Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L. and Hafler, D. A. 1990. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
12. Martin, R., Howell, M. D., Jaraquemada, D., Flerlage, M., Richert, J., Brostoff, S., Long, E. O. and McFarland, H. F. 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:19.
13. Critchfield, J. M., Racke, M. K., Zuniga-Pflucker, J. C., Cannella, B., Raine, C. S., Goverman, J. and Lenardo, M. J. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139.
14. Elliott, E. A., McFarland, H. I., Nye, S. H., Cofiell, R., Wilson, T. M., Wilking, J. A., Squinto, S. P., Matis, L. A. and Mueller, J. P. 1996. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98:1602.
15. St. Louis, J., Chan, E. L., Singh, B. and Strejan, G. H. 1997. Suppression of experimental allergic encephalomyelitis in the Lewis rat, by administration of an acylated synthetic peptide of myelin basic protein. J. Neuroimmunol. 73:90.
16. Khoury, S. J., Sayegh, M. H., Hancock, W. W., Gallon, L., Carpenter, C. B. and Weiner, H. L. 1993. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J. Exp. Med. 178:559.
17. Goss, J. A., Nakafusa, Y., Roland, C. R., Hickey, W. F. and Flye, M. W. 1994. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. J. Immunol. 153:3890.
18. Swierkosz, J. and Swanborg, R. H. 1977. Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism. J. Immunol. 119:1501.
19. Gaur, A., Wiers, B., Liu, A., Rothbard, J. and Fathman, C. G. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
20. Miller, S. D., Wetzig, R. P. and Claman, H. N. 1979. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J. Exp. Med. 149:758.
21. Vandenbark, A. A., Celnik, B., Vainiene, M., Miller, S. D. and Offner, H. 1995. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. J. Immunol. 155:5867.
22. Vandenbark, A. A., Vainiene, M., Ariail, K., Miller, S. D. and Offner, H. 1996. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes. J. Neurosci. Res. 45:430.
23. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., Al-Sabbagh, A.. Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E. and Hafler, D. A. 1994 Oral tolerence: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
24. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
25. Whitacre, C. C., Gienapp, I. E., Meyer, A., Cox, K. L. and Javed, N. 1996. Treatment of autoimmune disease by oral tolerence to autoantigens. Clin. Immunol. Immunopathol. 80:S31.
26. Wraith, D. C. 1996. Antigen-specific immunotherapy of autoimmune disease: a commentary. Clin. Exp. Immunol. 103:349.
27. Hoyne, G. F. and Lamb, J. R. 1997. Regulation of T cell function in mucosal tolarance. Immunol. Cell Biol. 75:197.
28. + T cells precedes the development of tolerance in vivo. Int. Immunol. 8:335.
29. Hoyne, G. F., O'Hehir, R. E., Wraith, D. C., Thomas, W. R. and Lamb, J. R. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178:1783.
30. Hoyne, G. F., Callow, M. G., Kuo, M.-C. and Thomas, W. R. 1994. Inhibition of T cell responses by feeding peptides containing major and cryptic epitopes. Studies with the Der pi allergen Immunology 83:190.
31. Metzler, B. and Wraith, D. C. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: inhibition of MHC binding affinity. Int. Immunol. 5:1159.
32. Dick, A. D., Cheng, Y. F., McKinnon, A., Liversidge, J. and Forrester, J. V. 1993. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br. J. Ophthalmol. 77:171.
33. Staines, N. A., Harper, N., Ward, F. J., Malmström, V., Holmdahl, R. and Bansal, S. 1996. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 103:368.
34. h2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
35. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J. Exp. Med. 178:889.
36. Harrison, L. C., Dempsey-Collier, M., Kramer, D. R. and Takahashi, K. 1996. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:2167.
37. h1-like cells and up-regulation of TGF-β mRNA in mononuclear cells. Ann. NY Acad. Sci. 778:273.
38. Bai, X. F., Shi, F. D., Xiao, B. G., Li, H. L., van der Meide, P. H. and Link, H. 1997 Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA. J. Neuroimmunol. 80:65.
39. Al-Sabbagh, A., Nelsion, P. A., Akselband, Y., Sobel, R. A. and Weiner, H. L. 1996. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell. Immunol. 171:111.
40. Deibler, G. E., Martensson, R. E. and Kies, M. W. 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:139.
41. Ben-Nun, A., Wekerle, H. and Cohen, I. 1981. The rapid isolation of clonable antigen specific T-lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195.
42. h1-type immune responses. Clin. Immunol. Immunopathol. 83:117.
43. Link, H., Olsson, O., Sun, J.-B., Wang, W.-Z., Andersson, G., Ekre, H.-P., Brenner, T., Abramsky, O. and Olsson, T. 1991. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87:2191.
44. Link, J., Fredrikson, S., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, Å. and Link H. 1994. Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann. Neurol. 35:197.
45. Vandenbark, A. A., Vainiene, M., Celnik, B., Hashim, G. A., Buenafe, A. and Offner, H. 1994. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides. J. Immunol. 153:852.
46. Javed, N. H., Gienapp, I. E., Cox, K. L. and Whitacre, C. C. 1995. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 155:1599.
47. Chen, Y., Inobe, J.-I., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
48. Whitacre, C. C., Gienapp, I. E., Orosz, C. G. and Bitmar, D. M. 1991. Oral tolerance in experimental autoimmune encephalomyelitis III: evidence for clonal anergy. J. Immunol. 147:2155.
49. Friedman, A. and Weiner, H. L. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl Acad. Sci. USA 91:6688.
50. Melamed, D. and Friedman, A. 1993. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23:935.
51. Miller, A., Lider, O. and Weiner, H. L. 1991. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174:791.
52. Miller, A., Lider, O., Abramsky, O. and Weiner, H. L. 1994. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur. J. Immunol. 24:1026.
53. Miller, A., Al-Sabbagh, A., Santos, L. M. B., Das, M. P. and Weiner, H. L. 1993. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151:7307.
54. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
55. + T cells specific for a pancreatic beta cell neoantigen. Immunity 2:573.
56. + T cells. J. Exp. Med. 185:405.
57. Vanderlugt, C. J. and Miller, S. D. 1996. Epitope spreading. Curr. Opin. Immunol. 8:831.
58. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P. J., Wraith, D. C., O'Garra, A., Fathman, C. G. and Steinman, L. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
59. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. K. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.